Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Grover

Showing results (211-220 of 391) with videos related to

Pageof 40
Sort By:
Journal of Clinical Epidemiology|September 29, 2001
Health-related quality of life with coronary heart disease prevention and treatmentL Lalonde, A E Clarke, L Joseph, et al.
Archives of Biochemistry and Biophysics|December 1, 1994
The role of oxalate in lignin peroxidase-catalyzed reduction: protection from compound III accumulationD C Goodwin, D P Barr, S D Aust, et al.
Archives of Biochemistry and Biophysics|September 1, 1988
Vanadium and lipid peroxidation: evidence for involvement of vanadyl and hydroxyl radicalR J Keller, R P Sharma, T A Grover, et al.
Alcoholism, Clinical and Experimental Research|April 1, 1993
Chronic cadmium exposure attenuates ethanol-induced hypoalgesia in the adult ratR T Burkey, J R Nation, C A Grover, et al.
Methods and Findings in Experimental and Clinical Pharmacology|November 20, 2001
Involvement of nitric oxide in the antiaggregatory effect of enalaprilR P Shankar, V K Bhargava, A Grover, et al.
The American Journal of Medicine|August 2, 2003
Evaluating the benefits of treating dyslipidemia: the importance of diabetes as a risk factorSteven A Grover, Louis Coupal, Hanna Zowall, et al.
International Journal of Biometeorology|March 1, 1981
Body water metabolism in high altitude natives during and after a stay at sea levelS C Jain, J Bardhan, Y V Swamy, et al.
JAMA|April 5, 1995
The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-CV H Hamilton, F E Racicot, H Zowall, et al.
JAMA|February 12, 1992
The benefits of treating hyperlipidemia to prevent coronary heart disease. Estimating changes in life expectancy and morbidityS A Grover, M Abrahamowicz, L Joseph, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 2, 2004
Changing trends in the hospital management of unstable angina: a drug utilization analysisK K Chandra, S Malhotra, M Gupta, et al.
Pageof 40

Showing results (211-220 of 391) with videos related to

Sort By:
Pageof 40
Journal of Clinical Epidemiology|September 29, 2001
Health-related quality of life with coronary heart disease prevention and treatmentL Lalonde, A E Clarke, L Joseph, et al.
Archives of Biochemistry and Biophysics|December 1, 1994
The role of oxalate in lignin peroxidase-catalyzed reduction: protection from compound III accumulationD C Goodwin, D P Barr, S D Aust, et al.
Archives of Biochemistry and Biophysics|September 1, 1988
Vanadium and lipid peroxidation: evidence for involvement of vanadyl and hydroxyl radicalR J Keller, R P Sharma, T A Grover, et al.
Alcoholism, Clinical and Experimental Research|April 1, 1993
Chronic cadmium exposure attenuates ethanol-induced hypoalgesia in the adult ratR T Burkey, J R Nation, C A Grover, et al.
Methods and Findings in Experimental and Clinical Pharmacology|November 20, 2001
Involvement of nitric oxide in the antiaggregatory effect of enalaprilR P Shankar, V K Bhargava, A Grover, et al.
The American Journal of Medicine|August 2, 2003
Evaluating the benefits of treating dyslipidemia: the importance of diabetes as a risk factorSteven A Grover, Louis Coupal, Hanna Zowall, et al.
International Journal of Biometeorology|March 1, 1981
Body water metabolism in high altitude natives during and after a stay at sea levelS C Jain, J Bardhan, Y V Swamy, et al.
JAMA|April 5, 1995
The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-CV H Hamilton, F E Racicot, H Zowall, et al.
JAMA|February 12, 1992
The benefits of treating hyperlipidemia to prevent coronary heart disease. Estimating changes in life expectancy and morbidityS A Grover, M Abrahamowicz, L Joseph, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 2, 2004
Changing trends in the hospital management of unstable angina: a drug utilization analysisK K Chandra, S Malhotra, M Gupta, et al.
Pageof 40